IXICO plc (AIM:IXI)
London · Delayed Price · Currency is GBP · Price in GBX 6.78
-0.10 (-1.45%)
May 6, 2026, 2:56 PM GMT
IXICO Market Cap
IXICO has a market cap or net worth of 14.99 million as of May 6, 2026. Its market cap has increased by 79.74% in one year.
Market Cap
14.99M
Enterprise Value
11.63M
Revenue
6.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.78
Market Cap Chart
Since October 15, 2013, IXICO's market cap has increased from 8.82M to 14.99M, an increase of 69.93%. That is a compound annual growth rate of 4.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 14.99M | 37.67% |
| Dec 31, 2025 | 10.89M | - |
| Dec 31, 2024 | 10.89M | 80.16% |
| Dec 29, 2023 | 6.04M | -50.98% |
| Dec 30, 2022 | 12.33M | -57.32% |
| Dec 31, 2021 | 28.89M | -40.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Poolbeg Pharma | 30.32M |
| Sareum Holdings | 27.96M |
| ImmuPharma | 25.83M |
| SkinBioTherapeutics | 25.27M |
| Arecor Therapeutics | 24.92M |
| Aptamer Group | 21.59M |
| Fusion Antibodies | 17.50M |
| Genflow Biosciences | 14.46M |